-
Psychometric Analysis of the EORTC QLQ-NMIBC24 Using Data from a Global Phase 2 Randomized Trial of Erdafitinib[1] in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Mar 10, 2025, 14:00 PM -
Frequency of Gram-Negative Bacteria at the Military Medical Center in Guatemala
Mar 10, 2025, 14:00 PM -
Pediatric Opioid Prescribing Patterns: Analyzing Trajectories Using Texas PDMP Data in the Context of AAP Guidelines
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Economic Burden of Metastatic Pancreatic Cancer: A US Commercial and Medicare Claims Analysis From 2020 to 2023
Mar 10, 2025, 14:00 PM -
Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data
Mar 10, 2025, 14:00 PM -
Cost per Response Analysis of Deucravacitinib and Biologic Treatments for Moderate to Severe Plaque Psoriasis From the Perspective of the Brazilian Private Healthcare System
Mar 10, 2025, 14:00 PM -
A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities
Mar 10, 2025, 14:00 PM -
Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047
Mar 10, 2025, 14:00 PM -
Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE
Mar 10, 2025, 14:00 PM -
Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR
Mar 10, 2025, 14:00 PM -
Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Gastric Cancer (GC) and Gastroesophageal Junction (GEJ) Adenocarcinoma
Mar 10, 2025, 14:00 PM -
Moving the Needle: Value and Use of Real-World Evidence in Oncology Clinical Pathways Decision-Making
Mar 10, 2025, 14:00 PM -
Cost-Efficiency Modeling of Conversion to Biosimilar Trastuzumab-qyyp in Early-Stage Breast Cancer in Medicare
Mar 10, 2025, 14:00 PM -
Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints
Mar 10, 2025, 14:00 PM -
Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review
Mar 10, 2025, 14:00 PM -
Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example
Mar 10, 2025, 14:00 PM -
Exploratory Comparison of Medication Costs Among Non-Hodgkin Lymphoma Patients With and Without Z Code Documentation
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling.
Mar 10, 2025, 14:00 PM -
The Importance of Medicare Advantage Plan Design and Impact on Health Equity
Mar 10, 2025, 14:00 PM -
Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire
Mar 10, 2025, 14:00 PM
